Last Updated: May 10, 2026

CLINICAL TRIALS PROFILE FOR VASOPRESSIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VASOPRESSIN

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004360 ↗	Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus	Completed	Northwestern University		1995-09-01	OBJECTIVES: I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus.
NCT00004360 ↗	Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus	Completed	National Center for Research Resources (NCRR)		1995-09-01	OBJECTIVES: I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus.
NCT00004363 ↗	Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus	Completed	Northwestern University		1995-12-01	OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VASOPRESSIN

Condition Name

Chart
Table

Condition Name for VASOPRESSIN
Intervention	Trials
Septic Shock	31
Hyponatremia	14
Healthy	14
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VASOPRESSIN
Intervention	Trials
Shock	37
Shock, Septic	35
Diabetes Insipidus	23
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VASOPRESSIN

Trials by Country

Map
Table

Trials by Country for VASOPRESSIN
Location	Trials
United States	334
Canada	28
Germany	23
Brazil	18
Italy	18
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VASOPRESSIN
Location	Trials
California	22
New York	20
Ohio	18
Texas	17
Illinois	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VASOPRESSIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VASOPRESSIN
Clinical Trial Phase	Trials
PHASE4	8
PHASE3	7
PHASE2	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VASOPRESSIN
Clinical Trial Phase	Trials
Completed	137
Recruiting	58
Unknown status	27
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VASOPRESSIN

Sponsor Name

Chart
Table

Sponsor Name for VASOPRESSIN
Sponsor	Trials
University Hospital, Basel, Switzerland	9
Institute of Liver and Biliary Sciences, India	8
Vantia Ltd	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VASOPRESSIN
Sponsor	Trials
Other	351
Industry	72
NIH	17
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.